2m 2m 2m 2m 2m 2m 2m
CABALETTA BIO (CABA)
NASDAQ
$2.78+$0.05 (+1.83%)
Price as of Sep 11, 2026 7:58 PM EDT- $462.9MMarket Cap
- 48.37%1-Year Change
- BiotechnologyIndustry
CABALETTA BIO (CABA)
$2.78+$0.05 (+1.83%)
CABA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.73 | ||
Change | -$0.01 (-0.36%) | ||
Open | $2.77 | ||
High | $2.89 | ||
Low | $2.67 | ||
Previous Close | $2.74 | ||
Volume | 7,437,306 | ||
30-Day Average Volume | 5,204,739 | ||
1-Week Change | -21.33% | ||
1-Month Change | -2.15% | ||
1-Year Change | 48.37% | ||
3-Year Change | -82.07% | ||
5-Year Change | -76.47% | ||
Fundamentals | |||
Shares Outstanding | 169.5M | ||
Total Assets | $256.7M | ||
Market Cap | $462.9M | ||
Enterprise Value | $237.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$51.0M | ||
Free Cash Flow | -$41.5M | ||
EBIT | -$50.5M | ||
EBITDA | -$50.1M | ||
Net Working Capital | $191.1M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue